Literature DB >> 26924027

Predictors of success of treatment of distal two thirds common bile duct strictures: A retrospective Cohort study over two years.

Hany M El-Haddad1, Mohamed I Kassem2, Gihan M Shehata3, Ahmad H Afifi4.   

Abstract

BACKGROUND: Distal biliary stricture is a challenging clinical condition that requires a co-ordinated multidisciplinary approach. THE AIM OF THIS WORK: was to evaluate the predictors of success of different treatment modalities of distal two thirds CBD strictures. PATIENTS AND METHODS: Data were retrieved retrospectively from the medical records of the patients with distal biliary strictures treated in the Main Alexandria University Hospital from June 2013 to June 2015. Patients were classified into three groups according to the intervention performed: (endoscopic, open surgical, and percutaneous). In addition to the forth group that was followed up without intervention.
RESULTS: The study included 282 patients. The mean age was 61.1 ± 10.8 years (25-78) years. The most frequent presenting symptom was jaundice. Pancreatic adenocarcinoma was the most common cause followed by fibrotic stricture secondary to stones.
CONCLUSION: In univariate analysis, the success of treatment was significantly associated with the pathology of the stricture of the distal two thirds CBD. In the multivariate analysis, only two factors were affecting the success of the treatment; the stricture length and site.
Copyright © 2016 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Distal common bile duct strictures; Jaundice; Multivariate analysis; Pancreatic

Mesh:

Year:  2016        PMID: 26924027     DOI: 10.1016/j.ijsu.2016.02.066

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  1 in total

1.  Percutaneous removal of common bile duct stones using a modified balloon technique.

Authors:  Yang Won Kim; Sang Min Lee; Ho Cheol Choi; Jung Ho Won; Jae Boem Na; Jae Min Cho; Dae Seob Choi; Mi Jung Park; Hwa Seon Shin; Ji Eun Kim; Sung Eun Park; Jong Joon Shim
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.